Recursion Pharmaceuticals uses AI in drug development, increasing success rates in lab and animal testing, with upcoming data readouts for five Phase 2 programs. The company is a "TechBio," with ...
AI is not overhyped. The potential requires equal attention to the less glamorous but more important role of data management.
一些您可能无法访问的结果已被隐去。
显示无法访问的结果